[
    [
        {
            "time": "",
            "original_text": "康希诺新冠疫苗商品名确定：克威莎！年产能可达3亿剂",
            "features": {
                "keywords": [
                    "康希诺",
                    "新冠疫苗",
                    "克威莎",
                    "年产能",
                    "3亿剂"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "康希诺新冠疫苗商品名确定：克威莎！年产能可达3亿剂",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "前三季度研发费用同比增长86.82% 康希诺明星产品有望年内上市",
            "features": {
                "keywords": [
                    "康希诺",
                    "研发费用",
                    "同比增长",
                    "明星产品",
                    "年内上市"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "前三季度研发费用同比增长86.82% 康希诺明星产品有望年内上市",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "思源股份、德源药业精选层申报材料获受理 累计受理企业达83家",
            "features": {
                "keywords": [
                    "思源股份",
                    "德源药业",
                    "精选层",
                    "申报材料",
                    "受理企业",
                    "83家"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "其他行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "思源股份、德源药业精选层申报材料获受理 累计受理企业达83家",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "鑫开元：打造中国最专业的“一站式”CRO平台",
            "features": {
                "keywords": [
                    "鑫开元",
                    "CRO平台",
                    "一站式",
                    "专业"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药服务"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "鑫开元：打造中国最专业的“一站式”CRO平台",
                "Correlation": 4,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "国资委副主任翁杰明：纵深推进“双百企业”综合改革 率先完成重点任务",
            "features": {
                "keywords": [
                    "国资委",
                    "翁杰明",
                    "双百企业",
                    "综合改革",
                    "重点任务"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "国企改革"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国资委副主任翁杰明：纵深推进“双百企业”综合改革 率先完成重点任务",
                "Correlation": 3,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "超20家中国公司参与 涉及药物30多款 Q3授权交易特点有这些",
            "features": {
                "keywords": [
                    "中国公司",
                    "药物",
                    "授权交易",
                    "Q3",
                    "特点"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "超20家中国公司参与 涉及药物30多款 Q3授权交易特点有这些",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]